Ann L. MacDougall, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 4,900 shares at $16.50 ($81K) on 2018-06-04, disclosed to the SEC on 2018-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.70 | 997 | $16K | 19.4% |
| 2 | $15.98 | 100 | $2K | 2.0% |
| 3 | $16.00 | 50 | $800 | 1.0% |
| 4 | $16.25 | 200 | $3K | 4.0% |
| 5 | $16.28 | 50 | $814 | 1.0% |
| 6 | $16.29 | 100 |
| $2K |
| 2.0% |
| 7 | $16.30 | 200 | $3K | 4.0% |
| 8 | $16.40 | 6 | $98 | 0.1% |
| 9 | $16.50 | 106 | $2K | 2.2% |
| 10 | $16.64 | 100 | $2K | 2.1% |
| 11 | $16.67 | 100 | $2K | 2.1% |
| 12 | $16.69 | 100 | $2K | 2.1% |
| 13 | $16.70 | 100 | $2K | 2.1% |
| 14 | $16.75 | 100 | $2K | 2.1% |
| 15 | $16.75 | 611 | $10K | 12.7% |
| 16 | $16.78 | 300 | $5K | 6.2% |
| 17 | $16.83 | 100 | $2K | 2.1% |
| 18 | $16.84 | 200 | $3K | 4.2% |
| 19 | $16.85 | 194 | $3K | 4.0% |
| 20 | $16.90 | 200 | $3K | 4.2% |
| 21 | $16.92 | 105 | $2K | 2.2% |
| 22 | $16.94 | 200 | $3K | 4.2% |
| 23 | $16.95 | 195 | $3K | 4.1% |
| 24 | $16.97 | 286 | $5K | 6.0% |
| 25 | $16.98 | 200 | $3K | 4.2% |
| Total | $16.51 avg | 4,900 | $81K | 100% |
| Filing → |
| OPNT | BUY | 2019-12-12 | $73K | — | Filing → |